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E-mail address: giuseppe.dalessio@unina.it (G. D’AThe data presented here show for the ﬁrst time that the protein known as ‘‘ribonuclease (RNase)
inhibitor’’ (RI or RNH1) is present not only in the cell cytosol, but also in mitochondria, the central
organelles in cell redox homeostasis. This ﬁnding directly correlates with the reported ability of RI to
protect the cell from oxidative stress, with its sensitivity to oxidation and reactivity as a reactive
oxygen species scavenger. While this study was carried out we also surprisingly discovered the pres-
ence of RI in the cell nucleus. We deem that these data open new views in the investigation on the
cellular role(s) of the RI.
Structured summary:
RI physically interacts with ATP synthase sub Alpha mitochondrial, Stress 70 Protein, Mitochondrial,
Calcium-binding mitochondrial carrier protein Aralar 2 ADP/ATP Translocase 2 Elongation factor Tu
and Cytochrome b-c1 complex Sub 2 by anti bait coimmunoprecipitation (View interaction)
PARP and RI colocalize by cosedimentation (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The label of ‘‘ribonuclease (RNase) inhibitor’’ (RI, also termed
RNH1) to a ubiquitous protein of about 50 kDa, acidic, very abun-
dant in the cell cytosol, with a high content of Cys residues, con-
sisting of 15 Leu repeats (LRR), has been for more than half a
century certainly correct. RI inhibits the great majority of the
extracellular RNases from the vertebrate superfamily, bound by
RI with very high afﬁnity and catalytically neutralized. The struc-
ture of RI, free or complexed to an RNase, has been determined
[1,2]. Extensive reviews have been published on RI structure and
function [3,4].
However, the physiological role of this protein has not been
conclusively deﬁned. It has been proposed that the role of RI in
the cell is that of a ‘‘sentry’’, to protect its cytosolic RNA from extra-chemical Societies. Published by E
clease; ROS, reactive oxygen
containing 0.2% Gelatin and
ansition pore; ANT, ADP/ATP
horesis in sodium dodecyl-
lessio).cellular RNases that may enter that compartment [5]. This hypoth-
esis is based on the following evidence: RI resistant RNases, such as
bovine seminal RNase [6] and onconase [7], are cytotoxic; non-
cytotoxic RNases, strongly inhibited by RI, become cytotoxic when
they are engineered into relatively RI-resistant RNases [8]; cells
manipulated to increase the RI levels become more resistant to
RNase cytotoxicity [5,8,9].
In contrast with the ‘‘sentry’’ hypothesis, it has been reported
that the removal of RI from cells, obtained through RNA silencing,
does not render these cells sensitive to non-cytotoxic RNases [10].
Moreover, cytotoxic RNases have been described [11] that bind RI
with high afﬁnity [12]. On the other hand, data have been accumu-
lating on a different research line. Hofsteenge and co-workers have
early reported that in cultured cells an oxidative insult with H2O2,
a general oxidant, or with diamide, a thiol speciﬁc oxidant, engen-
ders a severe cellular loss of RI as a protein [13]. More recently, it
has been reported that cells over-expressing RI becomemore resis-
tant to H2O2 stress [14], and that RI has a strong scavenging activ-
ity on reactive oxygen species (ROS) [15]. These data, and those
from a parallel investigation of the effects of oxidants and anti-
oxidants on normal and RI deprived cells, has led to the proposal
that RI plays the physiological role of a defensive system against
oxidative stress [16]. Furthermore, in cells stressed with arsenitelsevier B.V. All rights reserved.
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tivation of tRNAs and translational arrest [17,18].
The data presented here, collected through biochemical and
mass spectrometric analyses, as well as inspections by immunoﬂu-
orescence at the subcellular level, support the hypothesis of a key
physiological role of RI in redox homeostasis. They show for the
ﬁrst time that RI is present and reactive as a ROS scavenger not
only in the cell cytosol, but also in mitochondria, the organelles
central in the cell redox homeostasis. Furthermore, they have en-
abled us to illustrate how RI is surprisingly abundant also in the
cell nucleus.
These data and conclusions do not provide a complete, exhaus-
tive picture of the physiological signiﬁcance of RI in the cell, but
certainly open the way to completely novel approaches to the
investigation of the cellular role of the RI.
2. Materials and methods
2.1. Cell culture and extracts
HeLa and HCT cells were cultured in DMEM supplemented with
10% bovine fetal serum in standard conditions. Cell viability was
assessed with the Trypan Blue exclusion method. Cell extracts
were prepared in 1% NP-40 in Phosphate Buffered Saline (PBS) with
protease and phosphatase inhibitors (Roche). Surnatants were col-
lected after centrifugation at 18 000g for 30 min 4 C, then stored
at 80 C. In some experiments, cells were transfected at 80% con-
ﬂuence with Metafectene–Pro (Biointex) coated plasmid DNA, and
incubation lasted o/n to allow expression of the recombinant pro-
tein. Cytosolic and nuclear extracts were prepared as described
[19]. Cytosolic and mitochondrial fractions were prepared with
the Qproteome Mitochondria Isolation Kit (Qiagen). Protein con-
centration was measured by the Bradford method (Bio-Rad).
2.2. Immunoprecipitation and mass spectrometry analyses
The sequence encoding human RI was ampliﬁed with GoTaq
DNA polymerase (Promega) using the following primers:
50-GGGGGAATTCAATGAGCCTGGACATCC-30 (forward);
50-GGGGGGTCGACTCAGGAGATGACCCTC-30 (reverse);
bearing EcoRI and SalI restriction sites, respectively, at 50 ends, and
the plasmid pTRP-cRI as a template [20]. The ampliﬁed fragment
was then directionally inserted into the EcoRI/SalI sites of
p3xFlag-CMV-7.1 to facilitate selection of immune complexes with
M2 Anti-Flag Afﬁnity Gel (SIGMA). Lysates of HeLa cells transfected
with p3xFlag-CMV-7.1 or the recombinant p3xFlag-RI (about 2 mg)
were challenged with M2 Anti-Flag Afﬁnity Gel, the immune com-
plexes were separated in 10% polyacrylamide gel electrophoresis in
sodium dodecyl-sulfate (SDS–PAGE) and stained with colloidal
Coomassie Blue (Invitrogen). Relevant protein bands and the corre-
sponding gel slices from control immunoprecipitation were
excised and processed for liquid chromatography and tandem
mass spectrometry (LC/MS/MS) analyses, performed on an LC/
MSD Trap XCT Ultra equipped with a 1100 nanoHPLC system and
a chip cube (Agilent Technologies, Palo Alto, CA). Raw data were
used to query a non-redundant protein database using in-house
MASCOT software (Matrix Science, Boston, MA).
2.3. Western blotting
Cell lysates were separated in 8% or 10% SDS–PAGE, then blot-
ted on PVDF membranes (Bio-Rad) using HEP-1 electroblot appara-
tus (OWL) at 2.5 mA/cm2. After blocking, membranes wereincubated o/n with relevant primary antibodies, then washed
and incubated with secondary peroxidase-linked antibodies. Light
emission in the presence of Immobilon Western Chemilumines-
cent HRP Substrate (Millipore) was detected with the ChemiDoc
system (Bio-Rad).
2.4. Antibodies
Antibodies used in these analyses were: anti-RI rabbit poly-
clonal antibodies, a kind gift of Dr. Guo-Fu Hu, Department of
Pathology, Harvard Medical School, Boston, USA; an alternative
anti-RI monoclonal antibody (anti-RNH1 M07, Abnova); anti-
PARP-1 C2-10 monoclonal antibody (Enzo) directed to poly-
ADP-ribose polymerase as nuclear marker. Antibodies anti-GAPDH,
directed to glyceraldehyde-P dehydrogenase as cytosolic marker,
6C5 anti-tubulin, COX4 monoclonal antibody, and goat polyclonal
antibody anti-B23 as a nucleolar marker, were from Santa Cruz
Biotechnology. Alexa Fluor 488 goat anti-rabbit (Molecular
Probes). Peroxidase-linked secondary antibodies were anti-mouse
IgG (Fc speciﬁc) or anti-rabbit IgG goat polyclonal antibodies
(Sigma).
2.5. Immunoﬂuorescence and confocal microscopy
Cells growing on glass cover slips (in medium containing or not
250 nM Mitotracker Red as a mitochondrial dye, according to the
manufacturer’s protocol) were ﬁxed for 20 min in PBS containing
4% paraformaldehyde (Sigma), washed two times in 50 mM NH4Cl,
then with PBS GS (PBS containing 0.2% Gelatin and 0.075% Saponin,
from Sigma) and incubated in humidiﬁed atmosphere with the rel-
evant antibodies at room temperature. Cells were then washed
with PBS GS and incubated in humidiﬁed atmosphere at room tem-
perature with the secondary antibodies and with tetramethylrhod-
amine isothiocyanate (TRITC)–phalloidin as a dye speciﬁc for
microﬁlaments (Sigma), as indicated. As a negative control, cells
were also stained with secondary antibodies alone (not shown).
Nuclei were stained with DNA intercalants Hoechst 33258 or
DRAQ5 (Bio status, Alexis Corporation), as indicated. Cells were ﬁ-
nally mounted in 50% glycerol in PBS and analyzed with a Zeiss
LSM 510 Meta confocal microscope. The lambda of the argon ion
laser was set at 488 nm, those of the two HeNe lasers were set
one at 546, the other at 633 nm. Fluorescence emission was re-
vealed by BP 505–530 band pass ﬁlter for Alexa Fluor 488, by BP
560–615 band pass ﬁlter for TRITC–phalloidin or Mitotracker Red
and by 615 long pass ﬁlter for DRAQ5. Nuclei stained with Hoechst
33258 were acquired as non-confocal images by mean of a light
detector and 352/461 nm ﬁlter (UV light). Double- and triple stain-
ing immunoﬂuorescence images were acquired separately in the
green, red and infra red channels and then saved in TIFF format
to prevent the loss of information. They had been acquired with
a resolution of 1024  1024 pixels with the confocal pinhole set
to one Airey unit.
3. Results
3.1. Searching for proteins interacting with RI
We have designed co-immunoprecipitation experiments to
identify proteins interacting with RI in the cellular environment,
as a new approach to the understanding of its biological role. To
this end, lysates from HeLa cells transfected with the recombinant
vector p3xFlag-RI or control vectors, were challenged with anti-
Flag M2 afﬁnity Gel, then bound proteins were analyzed by SDS–
PAGE and stained with Coomassie Blue. The outcome revealed, in
addition to Flag-RI, a number of protein bands absent in the control
Table 1
Mitochondrial proteins speciﬁcally interacting with RI, the RNase/angiogenin inhib-
itor in HeLa cell lysates as identiﬁed by mass spectrometry. Peptides corresponding to
proteins listed in the table were totally absent in control immunoprecipitation.
Swiss-
Prot #
Protein MW Peptides
P38646 Stress 70 Protein Mitochondrial 73 680 8
Q9UJS0 Calcium-binding mitochondrial carrier
protein Aralar 2
74 176 10
P25705 ATP synthase sub Alpha mitochondrial 59 751 12
P49411 Elongation factor Tu 49 542 13
P22695 Cytochrome b-c1 complex Sub 2 48 443 5
P05141 ADP/ATP Translocase 2 32 895 9
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mass spectrometry analysis. The results (see Fig. S1) show that a
relevant group of interacting proteins belongs to the mitochondrial
inner membrane or matrix (see Table 1), suggesting that, in addi-
tion to the cytosolic compartments, RI appears to reside also inside
mitochondria.
3.2. RI is localized in mitochondria
We then tried a direct biochemical approach to detect the
presence of RI in mitochondria. The mitochondrial and cytosolic
fractions of transfected HeLa and HCT cells were analyzed byFig. 1. Subcellular localization of RI in HCT and HeLa cells transfected with p3xFlag or c
Western blotting with anti-Flag antibody (a-Flag), is detected not only in the cytosolic (c
anti-tubulin (a-tubulin) and anti-COX4 (a-COX4) antibodies as markers for cytosolic and
RI in HCT and HeLa cells is shown, revealed by Western blotting with anti-RI polyclonal
COX4) antibodies. 40 lg of each lysate were analyzed.Western blotting to identify 3xFlag-RI. The results (Fig. 1A and B)
show that a substantial amount of recombinant RI is associated
to the mitochondrial fractions. In addition, endogenous RI is re-
vealed by speciﬁc antibodies in the mitochondrial fractions of
untransfected cells (Fig. 1C), while an unrelated control antiserum
was unable to produce the signal (not shown).
To conﬁrm this ﬁnding, we performed an immunoﬂuorescence
confocal analysis of HeLa cells. The results (see Fig. 2) show that
endogenous RI largely colocalizes with mitochondria stained with
Mitotracker Red. As expected, RI is also present in the cytosol and,
surprisingly, also in the nuclear matrix.
3.3. Evidence of RI localization in the nucleus
We have validated the presence of RI in the nucleus by probing
HeLa cells nuclear extracts and cytosolic lysates with polyclonal
anti-RI antibodies. The results of Western blottings, shown in
Fig. 3, conﬁrm the presence of RI in the cell nucleus. The signal gen-
erated by a monoclonal anti-RI antibody in confocal immunoﬂuo-
rescence analyses (see Fig. 4A–C) is consistent with the results
shown in Figs. 2, 3 and 4D–G, in which the RI nuclear localization
is revealed by speciﬁc polyclonal antibodies. In confocal immuno-
ﬂuorescence analyses, both antibodies show the same very intense
and diffuse staining pattern of the nucleus, with the exception of
regions corresponding to nucleolar areas, identiﬁed by an antibodyontrol vector (mock). (A) Recombinant RI, revealed by SDS–PAGE 10% followed by
) but also in the mitochondrial (m) fractions. (B) The same lysates were blotted with
mitochondrial fractions, respectively. (C) The subcellular localization of endogenous
antibodies. Filters were re-blotted with anti-tubulin (a-tubulin) and anti-COX4 (a-
Fig. 2. Confocal microscopy showing signiﬁcant mitochondrial localization of endogenous RI in HeLa cells. Red: mitochondria stained with Mitotracker Red; green: a-RI
followed by Alexa ﬂuor 488-conjugated goat anti-rabbit IgG antibody; yellow: merge. Bars: 5 lm.
Fig. 3. Evidence of RI localization in the nucleus. Western blot analyses with anti-RI
polyclonal antibodies. Lanes 1 and 2: 2.5 or 5 lg of HeLa cells nuclear extracts; in
lanes 3 and 4: 2.5 or 5 lg of cytosolic lysates. The blot was re-probed with anti PARP
and anti-GAPDH antibodies as markers for nuclear and cytosolic extracts,
respectively.
616 A. Furia et al. / FEBS Letters 585 (2011) 613–617against the nucleolar marker phosphoprotein B23 (data not
shown).
4. Discussion
The result of our work uncover novel, previously unnoticed sub-
cellular localizations of RI. We have established that RI, known as a
cytosolic protein, is also present in the cell nucleus and mitochon-
dria. Association of RI with proteins of the mitochondrial inner
membrane and matrix place this protein in a major environmentof ROS production. The ability of RI to protect genome integrity
and cell viability from oxidative stress injury is documented in
the literature, and correlates well with the sensitivity to oxidation
and the in vitro activity as ROS scavenger of the protein [14–16].
Singh et al. have shown that apoptosis induced in HeLa cells by
H2O2 induced oxidative stress, depends on ROS generated in mito-
chondria [21]. HeLa cells on the other hand show increased resis-
tance to H2O2 induced mortality when RI is overexpressed [14].
The evidence reported here provides a new direct basis, through
experimental methodologies distinct from the others so far
proposed on the role of RI as a ROS scavenger. Interesting to note
protein ADP/ATP Translocase (ANT), co-immunoprecipitated with
RI, is a regulative component of the mitochondrial permeability
transition pore (MPTP), which plays a pivotal role in mitochondrial
induced cell death [21]. Oxidative stress promotes glutathione-
mediated oxidation of ANT cysteine residues located in matrix-
facing loops, resulting in Ca++ binding of the protein and activation
of MPTP [22]. Thus, we are tempting to speculate that ANT-
associated RI could act as a shield against ROS induced, GSH med-
iated oxidation of the nucleotide transporter. Oxidation of RI leads
to the formation of intramolecular disulﬁde bridges with an all-
or-none pattern, and to its rapid degradation in the cell [13]. We
have observed some degradation of endogenous RI in mitochon-
drial lysates (see Fig. 1C), a ﬁnding consistent with the hypothesis
that RI is easily oxidized in mitochondria due to the ROS rich
environment.
The identiﬁcation of RI in the nucleus is surprising; its role in
this cellular compartment is unknown. In immunoprecipitation
Fig. 4. Confocal microscopic analysis of HeLa cells. (A) Green ﬂuorescence associated with monoclonal anti-RI antibody. (B) Blue ﬂuorescence associated with Hoechst
staining, acquired as non-confocal images. (C) Merge between (A) and (B). RI is evident in the nuclear matrix, absent in nucleoli. Bars: 20 lm. (D) Green ﬂuorescence
associated with polyclonal anti-RI antibodies. (E) Nuclear blue ﬂuorescence after staining with DRAQ5. (F) Red ﬂuorescence after staining with TRITC-conjugated phalloidin.
(G) Merge between (D), (E) and (F). Bars: 10 lm.
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cept the nuclear pore membrane glycoprotein 210 (accession num-
ber Q8TEM1). This ﬁnding is in line with the observation that the
recombinant 3xFlagRI, perhaps due to the extension of 28 residues
at the amino end, does not enter the nucleus (not shown). While
the protein appears abundant in the nuclear matrix, it seems deﬁ-
nitely excluded from nucleoli. It can be assumed that in the reduc-
ing nuclear environment RI is in the thiol form, thus able to bind
and inhibit RNases, such as angiogenin. As angiogenin accumulates
in HeLa nucleoli, where it plays a key role in rRNA biogenesis [23],
the absence of RI, a powerful inhibitor of the enzyme, from the
nucleolar areas, would be consistent with this role of angiogenin.
In conclusion, the observations reported in this study offer new
evidence supporting the role of RI as a scavenger of ROS, and raise
intriguing new questions about its signiﬁcance and interactions in
the nucleus, thus opening new lines of investigation for an
advancement in the knowledge of RI functions in cell biology.
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